Location History:
- Washington, DC (US) (2012 - 2013)
- Lawrence, KS (US) (2003 - 2019)
Company Filing History:
8 out of 89 
6 out of 1,565 
Years Active: 2003-2019
Title: Lisa Timmons – A Pioneer in Genetic Inhibition
Introduction
Lisa Timmons is an innovative inventor based in Lawrence, Kansas, with a remarkable portfolio of eight patents. Her groundbreaking work primarily focuses on genetic inhibition through double-stranded RNA, providing crucial advancements in the field of genetic research and therapy.
Latest Patents
Among her latest patents is a process for introducing RNA into living cells to inhibit gene expression of target genes. This method can be applied both ex vivo and in vivo. The RNA features a region with a double-stranded structure, allowing for sequence-specific inhibition, where the nucleotide sequences of the duplex region of the RNA and the corresponding portion of the target gene are identical. This invention stands out by offering advantages over earlier methods of gene expression interference, which include antisense and triple-strand techniques.
Career Highlights
Throughout her career, Lisa Timmons has made significant contributions to genetic research. She has worked with esteemed institutions such as the Carnegie Institution of Washington and the University of Massachusetts, further solidifying her role as a leading innovator in her field.
Collaborations
Lisa has collaborated with notable scientists, including Andrew Fire and Stephen A. Kostas. These partnerships have enabled her to advance her research and further explore the potential of RNA-based genetic inhibition.
Conclusion
Lisa Timmons represents a vital force in the realm of genetic innovation. With her numerous patents and collaborations, she continues to pave the way for new methodologies in gene expression and inhibition, significantly impacting the scientific community and potential therapeutic applications.